{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,22]],"date-time":"2026-02-22T19:41:20Z","timestamp":1771789280946,"version":"3.50.1"},"reference-count":44,"publisher":"Spandidos Publications","issue":"4","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2017,4]]},"DOI":"10.3892\/ol.2017.5679","type":"journal-article","created":{"date-parts":[[2017,2,6]],"date-time":"2017-02-06T12:03:52Z","timestamp":1486382632000},"page":"2141-2150","source":"Crossref","is-referenced-by-count":15,"title":["Arsenic trioxide inhibits tumor-induced myeloid-derived suppressor cells and enhances T-cell activity"],"prefix":"10.3892","volume":"13","author":[{"given":"Qingmin","family":"Gao","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jingwei","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhaohui","family":"Chu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hao","family":"Lin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xinli","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiaohua","family":"Liang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"2249","published-online":{"date-parts":[[2017,2,6]]},"reference":[{"key":"key20180108112805_b1-ol-0-0-5679","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1038\/nrclinonc.2013.208","article-title":"Breathing new life into immunotherapy: review of melanoma, lung and kidney cancer","volume":"11","author":"Drake","year":"2014","journal-title":"Nat Rev Clin Oncol"},{"key":"key20180108112805_b2-ol-0-0-5679","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1053\/j.seminoncol.2014.02.003","article-title":"Myeloid-derived suppressor cells in cancer: therapeutic, predictive, and prognostic implications","volume":"41","author":"Diaz-Montero","year":"2014","journal-title":"Semin Oncol"},{"key":"key20180108112805_b3-ol-0-0-5679","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1038\/nrc3581","article-title":"History of myeloid-derived suppressor cells","volume":"13","author":"Talmadge","year":"2013","journal-title":"Nat Rev Cancer"},{"key":"key20180108112805_b4-ol-0-0-5679","doi-asserted-by":"crossref","first-page":"5791","DOI":"10.4049\/jimmunol.181.8.5791","article-title":"Subsets of myeloid-derived suppressor cells in tumor-bearing mice","volume":"181","author":"Youn","year":"2008","journal-title":"J Immunol"},{"key":"key20180108112805_b5-ol-0-0-5679","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1038\/nri2506","article-title":"Myeloid-derived suppressor cells as regulators of the immune system","volume":"9","author":"Gabrilovich","year":"2009","journal-title":"Nat Rev Immunol"},{"key":"key20180108112805_b6-ol-0-0-5679","doi-asserted-by":"crossref","first-page":"9299","DOI":"10.1158\/0008-5472.CAN-06-1690","article-title":"All-trans-retinoic acid improves differentiation of myeloid cells and immune response in cancer patients","volume":"66","author":"Mirza","year":"2006","journal-title":"Cancer Res"},{"key":"key20180108112805_b7-ol-0-0-5679","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1007\/s00262-003-0459-7","article-title":"Phase 1B study to improve immune responses in head and neck cancer patients using escalating doses of 25-hydroxyvitamin D3","volume":"53","author":"Lathers","year":"2004","journal-title":"Cancer Immunol Immunother"},{"key":"key20180108112805_b8-ol-0-0-5679","first-page":"3556","article-title":"Arsenic trioxide: an ancient drug revived","volume":"125","author":"Zhou","year":"2012","journal-title":"Chin Med J (Engl)"},{"key":"key20180108112805_b9-ol-0-0-5679","doi-asserted-by":"crossref","first-page":"3852","DOI":"10.1200\/JCO.2001.19.18.3852","article-title":"United States multicenter study of arsenic trioxide in relapsed acute promyelocytic leukemia","volume":"19","author":"Soignet","year":"2001","journal-title":"J Clin Oncol"},{"key":"key20180108112805_b10-ol-0-0-5679","doi-asserted-by":"crossref","first-page":"1680","DOI":"10.1158\/1535-7163.MCT-07-2164","article-title":"Arsenic trioxide decreases AKT protein in a caspase-dependent manner","volume":"7","author":"Mann","year":"2008","journal-title":"Mol Cancer Ther"},{"key":"key20180108112805_b11-ol-0-0-5679","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1046\/j.0007-1048.2001.03298.x","article-title":"Dual effects of arsenic trioxide (As2O3) on non-acute promyelocytic leukaemia myeloid cell lines: induction of apoptosis and inhibition of proliferation","volume":"116","author":"Rojewski","year":"2002","journal-title":"Br J Haematol"},{"key":"key20180108112805_b12-ol-0-0-5679","first-page":"3345","article-title":"Use of arsenic trioxide (As2O3) in the treatment of acute promyelocytic leukemia (APL): I. As2O3 exerts dose-dependent dual effects on APL cells","volume":"89","author":"Chen","year":"1997","journal-title":"Blood"},{"key":"key20180108112805_b13-ol-0-0-5679","first-page":"3893","article-title":"Mechanisms of action of arsenic trioxide","volume":"62","author":"Miller","year":"2002","journal-title":"Cancer Res"},{"key":"key20180108112805_b14-ol-0-0-5679","doi-asserted-by":"crossref","first-page":"1366","DOI":"10.3109\/10428194.2013.829573","article-title":"Artesunate possesses anti-leukemia properties that can be enhanced by arsenic trioxide","volume":"55","author":"Li","year":"2014","journal-title":"Leuk Lymphoma"},{"key":"key20180108112805_b15-ol-0-0-5679","doi-asserted-by":"crossref","first-page":"5171","DOI":"10.4049\/jimmunol.1103094","article-title":"Arsenic trioxide exerts antitumor activity through regulatory T cell depletion mediated by oxidative stress in a murine model of colon cancer","volume":"189","author":"Thomas-Schoemann","year":"2012","journal-title":"J Immunol"},{"key":"key20180108112805_b16-ol-0-0-5679","doi-asserted-by":"crossref","first-page":"292","DOI":"10.3109\/1547691X.2011.642418","article-title":"Paclitaxel promotes differentiation of myeloid-derived suppressor cells into dendritic cells in vitro in a TLR4-independent manner","volume":"9","author":"Michels","year":"2012","journal-title":"J Immunotoxicol"},{"key":"key20180108112805_b17-ol-0-0-5679","doi-asserted-by":"crossref","first-page":"1205","DOI":"10.1189\/jlb.1006640","article-title":"Mycobacteria-induced Gr-1+ subsets from distinct myeloid lineages have opposite effects on T cell expansion","volume":"81","author":"Dietlin","year":"2007","journal-title":"J Leukoc Biol"},{"key":"key20180108112805_b18-ol-0-0-5679","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1186\/1479-5876-9-90","article-title":"Functional characterization of human Cd33+ and Cd11b+ myeloid-derived suppressor cell subsets induced from peripheral blood mononuclear cells co-cultured with a diverse set of human tumor cell lines","volume":"9","author":"Lechner","year":"2011","journal-title":"J Transl Med"},{"key":"key20180108112805_b19-ol-0-0-5679","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/j.imlet.2014.10.012","article-title":"Scientific contributions toward successful cancer immunotherapy in The Netherlands","volume":"162","author":"Melief","year":"2014","journal-title":"Immunol Lett"},{"key":"key20180108112805_b20-ol-0-0-5679","doi-asserted-by":"crossref","first-page":"4233","DOI":"10.1182\/blood-2007-07-099226","article-title":"Identification of discrete tumor-induced myeloid-derived suppressor cell subpopulations with distinct T cell-suppressive activity","volume":"111","author":"Movahedi","year":"2008","journal-title":"Blood"},{"key":"key20180108112805_b21-ol-0-0-5679","doi-asserted-by":"crossref","first-page":"490","DOI":"10.1097\/PPO.0000000000000006","article-title":"Hampering immune suppressors: therapeutic targeting of myeloid-derived suppressor cells in cancer","volume":"19","author":"Albeituni","year":"2013","journal-title":"Cancer J"},{"key":"key20180108112805_b22-ol-0-0-5679","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1038\/nri746","article-title":"Mouse and human dendritic cell subtypes","volume":"2","author":"Shortman","year":"2002","journal-title":"Nat Rev Immunol"},{"key":"key20180108112805_b23-ol-0-0-5679","doi-asserted-by":"crossref","first-page":"775","DOI":"10.3892\/ol.2014.2174","article-title":"Downregulation of CD40 expression contributes to the accumulation of myeloid-derived suppressor cells in gastric tumors","volume":"8","author":"Shen","year":"2014","journal-title":"Oncol Lett"},{"key":"key20180108112805_b24-ol-0-0-5679","doi-asserted-by":"crossref","first-page":"7","DOI":"10.2220\/biomedres.30.7","article-title":"Potential differentiation of tumor bearing mouse CD11b+Gr-1+ immature myeloid cells into both suppressor macrophages and immunostimulatory dendritic cells","volume":"30","author":"Narita","year":"2009","journal-title":"Biomed Res"},{"key":"key20180108112805_b25-ol-0-0-5679","doi-asserted-by":"crossref","first-page":"941","DOI":"10.1038\/nri1498","article-title":"Mechanisms and functional significance of tumour-induced dendritic-cell defects","volume":"4","author":"Gabrilovich","year":"2004","journal-title":"Nat Rev Immunol"},{"key":"key20180108112805_b26-ol-0-0-5679","doi-asserted-by":"crossref","first-page":"19103","DOI":"10.1074\/jbc.M112.434530","article-title":"Deregulation of apoptotic factors Bcl-xL and Bax confers apoptotic resistance to myeloid-derived suppressor cells and contributes to their persistence in cancer","volume":"288","author":"Hu","year":"2013","journal-title":"J Biol Chem"},{"key":"key20180108112805_b27-ol-0-0-5679","doi-asserted-by":"crossref","first-page":"1916","DOI":"10.4049\/jimmunol.156.5.1916","article-title":"Suppression of T cell proliferation by tumor-induced granulocyte-macrophage progenitor cells producing transforming growth factor-beta and nitric oxide","volume":"156","author":"Young","year":"1996","journal-title":"J Immunol"},{"key":"key20180108112805_b28-ol-0-0-5679","doi-asserted-by":"crossref","first-page":"5500","DOI":"10.4049\/jimmunol.1103505","article-title":"MicroRNA-494 is required for the accumulation and functions of tumor-expanded myeloid-derived suppressor cells via targeting of PTEN","volume":"188","author":"Liu","year":"2012","journal-title":"J Immunol"},{"key":"key20180108112805_b29-ol-0-0-5679","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/j.ccr.2007.12.004","article-title":"Abrogation of TGF beta signaling in mammary carcinomas recruits Gr-1+CD11b+ myeloid cells that promote metastasis","volume":"13","author":"Yang","year":"2008","journal-title":"Cancer Cell"},{"key":"key20180108112805_b30-ol-0-0-5679","doi-asserted-by":"crossref","first-page":"989","DOI":"10.4049\/jimmunol.172.2.989","article-title":"Antigen-specific inhibition of CD8+ T cell response by immature myeloid cells in cancer is mediated by reactive oxygen species","volume":"172","author":"Kusmartsev","year":"2004","journal-title":"J Immunol"},{"key":"key20180108112805_b31-ol-0-0-5679","doi-asserted-by":"crossref","first-page":"1320","DOI":"10.4049\/jimmunol.1203195","article-title":"Transmembrane TNF-\u03b1 promotes suppressive activities of myeloid-derived suppressor cells via TNFR2","volume":"192","author":"Hu","year":"2014","journal-title":"J Immunol"},{"key":"key20180108112805_b32-ol-0-0-5679","doi-asserted-by":"crossref","first-page":"1178","DOI":"10.1038\/ni.1791","article-title":"Interleukin 10 acts on regulatory T cells to maintain expression of the transcription factor Foxp3 and suppressive function in mice with colitis","volume":"10","author":"Murai","year":"2009","journal-title":"Nat Immunol"},{"key":"key20180108112805_b33-ol-0-0-5679","doi-asserted-by":"crossref","first-page":"156","DOI":"10.3109\/00365521.2010.516450","article-title":"Up-regulated myeloid-derived suppressor cell contributes to hepatocellular carcinoma development by impairing dendritic cell function","volume":"46","author":"Hu","year":"2011","journal-title":"Scand J Gastroenterol"},{"key":"key20180108112805_b34-ol-0-0-5679","doi-asserted-by":"crossref","first-page":"1123","DOI":"10.1158\/0008-5472.CAN-05-1299","article-title":"Gr-1+CD115+ immature myeloid suppressor cells mediate the development of tumor-induced T regulatory cells and T-cell anergy in tumor-bearing host","volume":"66","author":"Huang","year":"2006","journal-title":"Cancer Res"},{"key":"key20180108112805_b35-ol-0-0-5679","doi-asserted-by":"crossref","first-page":"3367","DOI":"10.1172\/JCI35213","article-title":"Stat3 mediates myeloid cell-dependent tumor angiogenesis in mice","volume":"118","author":"Kujawski","year":"2008","journal-title":"J Clin Invest"},{"key":"key20180108112805_b36-ol-0-0-5679","first-page":"55","article-title":"Signaling pathways involved in MDSC regulation","volume":"1846","author":"Trikha","year":"2014","journal-title":"Biochim Biophys Acta"},{"key":"key20180108112805_b37-ol-0-0-5679","doi-asserted-by":"crossref","first-page":"798","DOI":"10.1038\/nrc2734","article-title":"STATs in cancer inflammation and immunity: a leading role for STAT3","volume":"9","author":"Yu","year":"2009","journal-title":"Nat Rev Cancer"},{"key":"key20180108112805_b38-ol-0-0-5679","doi-asserted-by":"crossref","first-page":"9525","DOI":"10.1158\/0008-5472.CAN-05-0529","article-title":"Regulation of dendritic cell differentiation and antitumor immune response in cancer by pharmacologic-selective inhibition of the janus-activated kinase 2\/signal transducers and activators of transcription 3 pathway","volume":"65","author":"Nefedova","year":"2005","journal-title":"Cancer Res"},{"key":"key20180108112805_b39-ol-0-0-5679","doi-asserted-by":"crossref","first-page":"5693","DOI":"10.4049\/jimmunol.0900092","article-title":"Mechanism regulating reactive oxygen species in tumor-induced myeloid-derived suppressor cells","volume":"182","author":"Corzo","year":"2009","journal-title":"J Immunol"},{"key":"key20180108112805_b40-ol-0-0-5679","doi-asserted-by":"crossref","first-page":"1580","DOI":"10.1172\/JCI60083","article-title":"STAT3 regulates arginase-I in myeloid-derived suppressor cells from cancer patients","volume":"123","author":"Vasquez-Dunddel","year":"2013","journal-title":"J Clin Invest"},{"key":"key20180108112805_b41-ol-0-0-5679","doi-asserted-by":"crossref","first-page":"2506","DOI":"10.1158\/0008-5472.CAN-08-4323","article-title":"Sunitinib inhibition of Stat3 induces renal cell carcinoma tumor cell apoptosis and reduces immunosuppressive cells","volume":"69","author":"Xin","year":"2009","journal-title":"Cancer Res"},{"key":"key20180108112805_b42-ol-0-0-5679","doi-asserted-by":"crossref","first-page":"697","DOI":"10.4049\/jimmunol.1002987","article-title":"A role for immature myeloid cells in immune senescence","volume":"186","author":"Enioutina","year":"2011","journal-title":"J Immunol"},{"key":"key20180108112805_b43-ol-0-0-5679","first-page":"457","article-title":"Membrane-associated Hsp72 from tumor-derived exosomes mediates STAT3-dependent immunosuppressive function of mouse and human myeloid-derived suppressor cells","volume":"120","author":"Chalmin","year":"2010","journal-title":"J Clin Invest"},{"key":"key20180108112805_b44-ol-0-0-5679","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1593\/tlo.12322","article-title":"Arsenic trioxide as a vascular disrupting agent: synergistic effect with irinotecan on tumor growth delay in a CT26 allograft model","volume":"6","author":"Lee","year":"2013","journal-title":"Transl Oncol"}],"container-title":["Oncology Letters"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/spandidos-publications.com\/10.3892\/ol.2017.5679\/download","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,8,22]],"date-time":"2023-08-22T03:18:21Z","timestamp":1692674301000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.spandidos-publications.com\/10.3892\/ol.2017.5679"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,2,6]]},"references-count":44,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2017,2,6]]},"published-print":{"date-parts":[[2017,4]]}},"alternative-id":["10.3892\/ol.2017.5679"],"URL":"https:\/\/doi.org\/10.3892\/ol.2017.5679","relation":{},"ISSN":["1792-1074","1792-1082"],"issn-type":[{"value":"1792-1074","type":"print"},{"value":"1792-1082","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,2,6]]}}}